Pregnenolone

From NuGOwiki

(Redirected from HMDB00253)
Jump to: navigation, search

The NuGOwiki Metabolite Database is a joint initiative of NuGO and HMDB

Taxonomy Navigation Box; search by

All Metabolites | Biochemical | Nutritional | Functional | Metabolic Pathways | Diseases | Phenotypes | Physiological Processes | Protein

Pregnenolone
2D structure for Pregnenolone
Chemical Name 1-[(3S,8S,9S,10R,13S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone
Chemical Formula C21H32O2
CAS Number 145-13-1
Chemical Information HMDB00253
Biochemical Taxonomy

  • Steroids and Steroid Derivatives

Functional Taxonomy Not Available
Nutritional Taxonomy Not Available
Metabolic Pathways

  • Androgen and Estrogen Metabolism
  • C21-Steroid Hormone Metabolism

Biofluid Location

  • Blood
  • Cerebrospinal Fluid (CSF)

Tissue Location

  • Adrenal Gland
  • Brain
  • Gonads
  • Kidney
  • Myelin
  • Nerves
  • Neurons
  • Placenta
  • Testes
  • Testis
  • Adrenal Cortex

Normal Biofluid Concentrations

  • Blood: 0.0008 +/- 0.0008 uM
  • Blood: 0.014 +/- 0.008 umol/L
  • Cerebrospinal Fluid (CSF): 0.00013 (0.000082-0.00019) uM

Normal Tissue Concentrations Not Available
Diseases / Conditions Related to Nutrition

  • Depressed pregnant woman
  • Premenstrual dysphoric disorder

Other (Monogenic Disorders)

Abnormal Biofluid Concentrations

  • Blood (Depressed pregnant woman): 0.068 +/- 0.02 uM
  • Blood (Premenstrual dysphoric disorder): 0.00082 +/- 0.0007 uM

Abnormal Tissue Concentrations Not Available
Physiological Processes Not Available
Authors:
Affiliations:

Contents

Introduction

guidelines
Pregnenolone is a derivative of cholesterol, the product of Cytochrome P450 side-chain cleavage (EC 1.14.15.6, CYP11A1); this reaction consists of three consecutive monooxygenations; a 22-hydroxylation, 20-hydroxylation and the cleavage of the C20-C22 bond, yielding pregnenolone. Pregnenolone is the precursor to gonadal steroid hormones and the adrenal corticosteroids. This reaction occurs in steroid hormone-producing tissues such as the adrenal cortex, corpus luteum and placenta. The most notable difference between the placenta and other steroidogenic tissues is that electron supply to CYP11A1 limits the rate at which cholesterol is converted to pregnenolone in the placenta. The limiting component for electron delivery to CYP11A1 is the concentration of adrenodoxin reductase in the mitochondrial matrix which is insufficient to maintain the adrenodoxin pool in a fully reduced state. Pregnenolone is also a neurosteroid, and is produced in the spinal cord; CYP11A1 is the key enzyme catalyzing the conversion of cholesterol into pregnenolone, the rate-limiting step in the biosynthesis of all classes of steroids, and has been localized in sensory networks of the spinal cord dorsal horn. In the adrenal glomerulosa cell angiotensin II, one of the major physiological regulators of mineralocorticoid synthesis, appears to affect most of the cholesterol transfer to the mitochondrial outer membrane and transport to the inner membrane steps and thus to exerts a powerful control over the use of cholesterol for aldosterone production. (PMID: 17222962, 15823613, 16632873, 15134809)

Biological Function

guidelines

Catabolism

guidelines

Diseases / Conditions Related to Nutrition

guidelines

  • Depressed pregnant woman
  • Premenstrual dysphoric disorder

Other (Monogenic) Disorders

guidelines

Nutritional Information

guidelines

Drivers for biological variation

guidelines

Vulnerable groups

guidelines

Other resources

guidelines

Links

guidelines